This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Mental Health Issues in Endurance Athletes.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05768841
Recruitment Status : Recruiting
First Posted : March 14, 2023
Last Update Posted : May 11, 2023
Sponsor:
Collaborators:
Hospital Universitario del Vinalopo
Universidade do Porto
University of South Africa
Information provided by (Responsible Party):
Volker Scheer, Ultra Sports Science Foundation

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Participation in endurance sports has been increasing over the last few decades and our aim of our exploratory descriptive survey study is therefore to examine mental health issues in endurance athletes (marathon runners, ultra endurance runners, triathletes), employing the IOC assessment tool, to provide information on mental health issues in this population. Secondary objects are to evaluate risk factors for mental health issues in endurance athletes (like exercise behaviour, competition behaviour, age, gender, medical issues)

Condition or disease Intervention/treatment
Depression, Anxiety Mental Health Issue Behavioral: mental health issues

Detailed Description:

This study is an exploratory descriptive survey study.

The study protocol will be largely replicated from the IOC consensus paper and the questionnaires based according to SMHAT 1 with an athlete-specific screening tool (APSQ) and further eleven subsequent disorder-specific screening tools:

Eleven disorder specific screening tools:

  1. General Anxiety Disorder-7 (GAD-7): assesses the presence of symptoms of anxiety.
  2. Patient Health Questionnaire-9 (PHQ-9): assesses the presence of symptoms of depression.
  3. Athlete Sleep Screening Questionnaire (ASSQ): assesses the presence of sleep disturbance.
  4. Alcohol Use Disorders Identification Test Consumption (AUDIT-C): assesses the presence of alcohol misuse.
  5. Cutting Down, Annoyance by Criticism, Guilty Feeling, and Eye-openers Adapted to Include Drugs (CAGE-AID): assesses the presence of substance misuse, being slightly adapted for the SMHAT (no focus on alcohol use as already explored with the AUDIT-C; additional question to explore which substance was used).
  6. Brief Eating Disorder in Athletes Questionnaire (BEDA-Q): assesses the presence of disordered eating.
  7. ADHD
  8. Bipolar disorder
  9. PTSD
  10. Gambling
  11. Psychosis

Additionally questions to assess exercise addiction will be used as it has been shown that exercise addiction may be particularly prevalent in endurance athletes.

Further questions about age, gender, country of origin, training data, past medical history and medication will be asked as well as a few specific questions about there thoughts on mental health issues as per IOC consensus paper

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Mental Health Issues in Endurance Athletes.
Actual Study Start Date : March 15, 2023
Estimated Primary Completion Date : September 30, 2023
Estimated Study Completion Date : September 30, 2023

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
endurance athletes
participants that have or are participating in endurance sports
 Behavioral: mental health issues
survey on mental health issues in endurance athletes


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of participants with mental health issues [ Time Frame: March-September 2023 ]
    Number of participants with mental health issues


Secondary Outcome Measures :
  1. Number of participants with risk factors associated with mental health issues [ Time Frame: March-September 2023 ]
    Number of participants with risk factors associated with mental health issues


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Particpants that have or are participating in endurance sports
Criteria

Inclusion Criteria:

  • endurance athletes (marathon runners, ultramarathon runners and triathletes)
  • over the age of 16
  • all genders
  • recreational athletes (non- elite)
  • elite athletes (professional, international, college level)

Exclusion Criteria:

  • athletes that that are not competing or have not competed in an official endurance race
  • athletes that are younger than 16 years of age.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05768841


Contacts
Layout table for location contacts
Contact: Volker Scheer, Prof +33 4 25 36 79 54 contact@ultrasportsscience.org

Locations
Layout table for location information
France
Ultra Sports Science Foundation Recruiting
Pierre-Bénite, France, 69310
Contact: Volker Scheer, Prof    +33 (0)4 25 36 79 54    contact@ultrasportsscience.org   
Sponsors and Collaborators
Ultra Sports Science Foundation
Hospital Universitario del Vinalopo
Universidade do Porto
University of South Africa
Investigators
Layout table for investigator information
Principal Investigator: Volker Scheer, Prof Ultra Sports Science Foundation
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Volker Scheer, Professor, Ultra Sports Science Foundation
ClinicalTrials.gov Identifier: NCT05768841    
Other Study ID Numbers: VS1
First Posted: March 14, 2023    Key Record Dates
Last Update Posted: May 11, 2023
Last Verified: May 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: anonymous

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms